Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1882 1
1956 1
1957 1
1964 1
1965 3
1966 1
1968 3
1969 4
1970 1
1971 3
1972 5
1973 3
1974 2
1975 5
1976 13
1977 19
1978 11
1979 10
1980 15
1981 17
1982 19
1983 26
1984 38
1985 31
1986 38
1987 39
1988 47
1989 67
1990 74
1991 78
1992 101
1993 129
1994 156
1995 178
1996 187
1997 172
1998 161
1999 152
2000 153
2001 141
2002 153
2003 175
2004 185
2005 215
2006 228
2007 284
2008 265
2009 268
2010 325
2011 330
2012 364
2013 390
2014 381
2015 439
2016 410
2017 456
2018 493
2019 525
2020 611
2021 687
2022 441
Text availability
Article attribute
Article type
Publication date

Search Results

8,753 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Jestratijevic
Page 1
Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
Sawamoto K, Álvarez González JV, Piechnik M, Otero FJ, Couce ML, Suzuki Y, Tomatsu S. Sawamoto K, et al. Int J Mol Sci. 2020 Feb 23;21(4):1517. doi: 10.3390/ijms21041517. Int J Mol Sci. 2020. PMID: 32102177 Free PMC article. Review.
Mucopolysaccharidosis type IVA (MPS IVA, or Morquio syndrome type A) is an inherited metabolic lysosomal disease caused by the deficiency of the N-acetylglucosamine-6-sulfate sulfatase enzyme. ...GAG accumulation in these lesions leads to unique skeletal dysplasia i …
Mucopolysaccharidosis type IVA (MPS IVA, or Morquio syndrome type A) is an inherited metabolic lysosomal disease caused by the …
Mucopolysaccharidosis Type IVA.
Regier DS, Oetgen M, Tanpaiboon P. Regier DS, et al. 2013 Jul 11 [updated 2021 Jun 17]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. 2013 Jul 11 [updated 2021 Jun 17]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. PMID: 23844448 Free Books & Documents. Review.
CLINICAL CHARACTERISTICS: The phenotypic spectrum of mucopolysaccharidosis IVA (MPS IVA) is a continuum that ranges from a severe and rapidly progressive early-onset form to a slowly progressive later-onset form. ...Compression of the spinal cord is a common complic …
CLINICAL CHARACTERISTICS: The phenotypic spectrum of mucopolysaccharidosis IVA (MPS IVA) is a continuum that ranges from a sev …
Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review.
Dagenais RVE, Su VCH, Quon BS. Dagenais RVE, et al. J Clin Med. 2020 Dec 23;10(1):23. doi: 10.3390/jcm10010023. J Clin Med. 2020. PMID: 33374882 Free PMC article. Review.
The objectives of this systematic review were to summarize real-world AEs reported for market-available CFTR modulators (i.e., ivacaftor (IVA), lumacaftor/ivacaftor (LUM/IVA), tezacaftor/ivacaftor (TEZ/IVA), and elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IV
The objectives of this systematic review were to summarize real-world AEs reported for market-available CFTR modulators (i.e., ivacaftor ( …
Diagnosing mucopolysaccharidosis IVA.
Wood TC, Harvey K, Beck M, Burin MG, Chien YH, Church HJ, D'Almeida V, van Diggelen OP, Fietz M, Giugliani R, Harmatz P, Hawley SM, Hwu WL, Ketteridge D, Lukacs Z, Miller N, Pasquali M, Schenone A, Thompson JN, Tylee K, Yu C, Hendriksz CJ. Wood TC, et al. J Inherit Metab Dis. 2013 Mar;36(2):293-307. doi: 10.1007/s10545-013-9587-1. Epub 2013 Feb 1. J Inherit Metab Dis. 2013. PMID: 23371450 Free PMC article.
Mucopolysaccharidosis IVA (MPS IVA; Morquio A syndrome) is an autosomal recessive lysosomal storage disorder resulting from a deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS) activity. ...Urinary glycosaminoglycan analysis is particularly problematic …
Mucopolysaccharidosis IVA (MPS IVA; Morquio A syndrome) is an autosomal recessive lysosomal storage disorder resulting from a …
Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.
Tomatsu S, Montaño AM, Oikawa H, Smith M, Barrera L, Chinen Y, Thacker MM, Mackenzie WG, Suzuki Y, Orii T. Tomatsu S, et al. Curr Pharm Biotechnol. 2011 Jun;12(6):931-45. doi: 10.2174/138920111795542615. Curr Pharm Biotechnol. 2011. PMID: 21506915 Review.
Mucopolysaccharidosis IVA (MPS IVA), also known as Morquio A, is a rare, autosomal recessive disorder caused by a deficiency of the lysosomal enzyme N-acetylgalatosamine-6-sulfate-sulfatase (GALNS), which catalyzes a step in the catabolism of glycosaminoglycans (GAG …
Mucopolysaccharidosis IVA (MPS IVA), also known as Morquio A, is a rare, autosomal recessive disorder caused by a deficiency o …
Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management.
Solanki GA, Martin KW, Theroux MC, Lampe C, White KK, Shediac R, Lampe CG, Beck M, Mackenzie WG, Hendriksz CJ, Harmatz PR. Solanki GA, et al. J Inherit Metab Dis. 2013 Mar;36(2):339-55. doi: 10.1007/s10545-013-9586-2. Epub 2013 Feb 6. J Inherit Metab Dis. 2013. PMID: 23385297 Free PMC article. Review.
Mucopolysaccharidosis IVA (MPS IVA), also known as Morquio-Brailsford or Morquio A syndrome, is a lysosomal storage disorder caused by a deficiency of the enzyme N-acetyl-galactosamine-6-sulphate sulphatase (GALNS). MPS IVA is multisystemic but manifests prim …
Mucopolysaccharidosis IVA (MPS IVA), also known as Morquio-Brailsford or Morquio A syndrome, is a lysosomal storage disorder c …
Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.
Peracha H, Sawamoto K, Averill L, Kecskemethy H, Theroux M, Thacker M, Nagao K, Pizarro C, Mackenzie W, Kobayashi H, Yamaguchi S, Suzuki Y, Orii K, Orii T, Fukao T, Tomatsu S. Peracha H, et al. Mol Genet Metab. 2018 Sep;125(1-2):18-37. doi: 10.1016/j.ymgme.2018.05.004. Epub 2018 May 15. Mol Genet Metab. 2018. PMID: 29779902 Free PMC article. Review.
Mucopolysaccharidosis IVA (MPS IVA, Morquio A syndrome) is an autosomal recessive disorder caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase. ...In this review article, we comprehensively describe clinical, radiographic, biochemical, and molecula …
Mucopolysaccharidosis IVA (MPS IVA, Morquio A syndrome) is an autosomal recessive disorder caused by the deficiency of N-acety …
Insights into the diversification of subclade IVa bHLH transcription factors in Fabaceae.
Suzuki H, Seki H, Muranaka T. Suzuki H, et al. BMC Plant Biol. 2021 Feb 23;21(1):109. doi: 10.1186/s12870-021-02887-w. BMC Plant Biol. 2021. PMID: 33622255 Free PMC article.
We aimed to systematically elucidate the diversification of this subclade and obtain insights into the evolutionary history of saponin biosynthesis regulation in Fabaceae. RESULTS: In this study, we collected sequences of subclade IVa bHLH proteins from 40 species, includi …
We aimed to systematically elucidate the diversification of this subclade and obtain insights into the evolutionary history of saponin biosy …
Biopharmaceutics classification and intestinal absorption of chikusetsusaponin IVa.
Zhang W, Liu H, Liu C. Zhang W, et al. Biopharm Drug Dispos. 2019 Sep;40(8):276-281. doi: 10.1002/bdd.2200. Epub 2019 Jul 28. Biopharm Drug Dispos. 2019. PMID: 31294470
The equilibrium solubility of CHS-IVa was determined by the shaker method. The absorption mechanism of CHS-IVa in the intestine was studied by comparing the P(eff) of different concentrations of CHS-IVa. ...The permeability of CHS-IVa was investigated …
The equilibrium solubility of CHS-IVa was determined by the shaker method. The absorption mechanism of CHS-IVa in the intestin …
Ethnomedicinal use, phytochemistry, pharmacology, and toxicology of Ajuga iva (L.,) schreb.
Bouyahya A, El Omari N, Elmenyiy N, Guaouguaou FE, Balahbib A, El-Shazly M, Chamkhi I. Bouyahya A, et al. J Ethnopharmacol. 2020 Aug 10;258:112875. doi: 10.1016/j.jep.2020.112875. Epub 2020 May 6. J Ethnopharmacol. 2020. PMID: 32387464 Review.
ETHNOPHARMACOLOGICAL RELEVANCE: Ajuga iva (L.,) Schreb (A. iva). is a medicinal plant commonly used in Africa to treat several diseases such as diabetes, rheumatism, allergy, cancer, renal, metabolic disorders, cardiovascular disorders, digestive, and respiratory di …
ETHNOPHARMACOLOGICAL RELEVANCE: Ajuga iva (L.,) Schreb (A. iva). is a medicinal plant commonly used in Africa to treat several …
8,753 results